Bruker

BRKR · NASDAQ

$55.93+$0.56 (+1.01%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $55.37

Latest news

Press releaseOct 20, 4:01 PM ETBusiness Wire
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast
Press releaseOct 6, 7:00 AM ETBusiness Wire
Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution
Press releaseSep 28, 7:00 AM ETBusiness Wire
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research
Press releaseSep 21, 7:00 AM ETBusiness Wire
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley
NewsSep 16, 9:57 AM ETAvi Kapoor
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
Press releaseSep 8, 1:21 PM ETBusiness Wire
Bruker Corporation to Present at Upcoming Investor Conferences
Press releaseSep 4, 2:00 AM ETBusiness Wire
BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion
NewsAug 31, 1:47 PM ETVandana Singh
Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit
Press releaseAug 11, 7:00 AM ETBusiness Wire
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories
Press releaseAug 10, 7:00 AM ETBusiness Wire
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development
NewsAug 4, 1:07 PM ETPiero Cingari
S&P 500 Hits Record Highs, Palantir Jumps 27%: Stock Market Today
NewsAug 4, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsAug 4, 8:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsAug 4, 7:01 AM ET
Bruker Q2 Adj. EPS $0.49 Beats $0.39 Estimate, Sales $838.500M Miss $853.543M Estimate
Press releaseAug 4, 7:00 AM ETBusiness Wire
Bruker Reports Second Quarter 2026 Financial Results
Press releaseJul 24, 4:01 PM ETBusiness Wire
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
Press releaseJul 15, 7:00 AM ETBusiness Wire
Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
Press releaseJun 4, 7:00 AM ETBusiness Wire
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026
Press releaseJun 2, 11:24 AM ETBusiness Wire
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry
Press releaseJun 1, 7:00 AM ETBusiness Wire
Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology
Press releaseMay 26, 7:00 AM ETBusiness Wire
Champalimaud Foundation's Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
NewsMay 6, 9:05 AM ET
Full Transcript: Bruker Q1 2026 Earnings Call
Press releaseMay 6, 6:30 AM ETBusiness Wire
Bruker Reports First Quarter 2026 Financial Results
Press releaseApr 24, 7:00 AM ETBusiness Wire
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
Press releaseApr 17, 9:00 AM ETBusiness Wire
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026
Press releaseApr 17, 6:00 AM ETBusiness Wire
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management
Press releaseApr 17, 6:00 AM ETBusiness Wire
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026
Press releaseApr 13, 7:00 AM ETBusiness Wire
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026
Press releaseApr 7, 7:00 AM ETBusiness Wire
Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research
Press releaseApr 1, 7:00 AM ETBusiness Wire
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
Press releaseMar 31, 1:07 PM ETBusiness Wire
PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge
Press releaseFeb 25, 7:00 AM ETBusiness Wire
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
Press releaseFeb 12, 7:00 AM ETBusiness Wire
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
NewsFeb 11, 12:01 PM ET
A Glimpse of Bruker's Earnings Potential
Press releaseFeb 5, 4:05 PM ETBusiness Wire
Bruker Announces Quarterly Preferred Stock Dividend
Press releaseNov 4, 4:01 PM ETBusiness Wire
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
Press releaseNov 3, 7:00 AM ETBusiness Wire
Bruker Reports Third Quarter 2025 Financial Results
NewsSep 16, 5:00 PM ET
A Look Into Bruker Inc's Price Over Earnings
Press releaseSep 3, 11:37 PM ETBusiness Wire
Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock
NewsSep 3, 12:27 PM ETAvi Kapoor
Crude Oil Falls Over 2%; Campbell's Earnings Top Estimates
NewsSep 2, 4:03 PM ET
Bruker Launches $600M Public Offering Of Mandatory Convertible Preferred Stock, To Repay Debt And Boost Strategic Flexibility
NewsJul 3, 11:22 AM ETTim Melvin
Alpha Buying: When Leadership Buys, Should You Follow?
Press releaseJun 3, 11:00 AM ETBusiness Wire
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast

Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution

Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research

Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley

LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday

Bruker Corporation to Present at Upcoming Investor Conferences

BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

S&P 500 Hits Record Highs, Palantir Jumps 27%: Stock Market Today

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Bruker Q2 Adj. EPS $0.49 Beats $0.39 Estimate, Sales $838.500M Miss $853.543M Estimate

Bruker Reports Second Quarter 2026 Financial Results

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology

Champalimaud Foundation's Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI

Earnings Scheduled For May 6, 2026

Full Transcript: Bruker Q1 2026 Earnings Call

Bruker Reports First Quarter 2026 Financial Results

Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management

Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026

Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026

Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research

Bruker Announces Appointment of Thierry Bernard to its Board of Directors

PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge

Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR

Bruker Reports Fourth Quarter and Full Year 2025 Financial Results

A Glimpse of Bruker's Earnings Potential

Bruker Announces Quarterly Preferred Stock Dividend

Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend

Bruker Reports Third Quarter 2025 Financial Results

A Look Into Bruker Inc's Price Over Earnings

Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock

Crude Oil Falls Over 2%; Campbell's Earnings Top Estimates

Bruker Launches $600M Public Offering Of Mandatory Convertible Preferred Stock, To Repay Debt And Boost Strategic Flexibility

Alpha Buying: When Leadership Buys, Should You Follow?

Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection